Healthy volunteers help map normal pancreatic fluid

NCT ID NCT07285863

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study aims to collect and analyze pancreatic fluid from 24 healthy adults after giving them a synthetic hormone called secretin. The secretin is injected during an endoscopic ultrasound to stimulate the pancreas to release fluid, which is then collected from the duodenum. Researchers will measure levels of bicarbonate, sodium, potassium, and chloride to better understand normal pancreatic fluid composition. This knowledge may help improve diagnosis and monitoring of pancreatic diseases like chronic pancreatitis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
human secretin (CHIROSTIM)
What this could lead to
If successful, this study could help establish normal ranges for pancreatic fluid components, improving diagnosis of pancreatic conditions like chronic pancreatitis.
What could go wrong
This is a small, early-phase study in healthy volunteers, not a treatment trial. Results may not directly apply to patients with pancreatic disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.